<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE325nnn/GSE325086/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE325086</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Ceramide-induced Endoplasmic Reticulum Stress as a Targetable Vulnerability in Endocrine Therapy-Resistant Breast Cancer</name><description>10 µM C8-ceramide treated to endocrine therapy (ET) sensitive parental MCF-7 cells along with three of its ET-resistant derivative cell lines (MCF-7-HER2, MCF-7-TAMR, and MCF-7-FULR) for 24 hours. Total RNAseq was performed on triplicate samples from each group to compare C8-ceramide actions in ET-sensitive and ET-resistant breast cancer cells.</description><dates><publication>2026/05/15</publication></dates><accession>GSE325086</accession><cross_references><GSM>GSM9595721</GSM><GSM>GSM9595710</GSM><GSM>GSM9595720</GSM><GSM>GSM9595723</GSM><GSM>GSM9595712</GSM><GSM>GSM9595722</GSM><GSM>GSM9595711</GSM><GSM>GSM9595703</GSM><GSM>GSM9595725</GSM><GSM>GSM9595714</GSM><GSM>GSM9595724</GSM><GSM>GSM9595713</GSM><GSM>GSM9595702</GSM><GSM>GSM9595716</GSM><GSM>GSM9595705</GSM><GSM>GSM9595715</GSM><GSM>GSM9595704</GSM><GSM>GSM9595718</GSM><GSM>GSM9595707</GSM><GSM>GSM9595706</GSM><GSM>GSM9595717</GSM><GSM>GSM9595709</GSM><GSM>GSM9595719</GSM><GSM>GSM9595708</GSM><GPL>24676</GPL><GSE>325086</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>